Men at an above-normal risk of prostate cancer may be able to reduce their risk of developing the disease by taking a drug already on the market.
In research reported Wednesday, the drug dutasteride, currently used to shrink enlarged prostates, was found to reduce the risk of prostate cancer by about a quarter in high-risk men. The medication, sold under the brand name Avodart, apparently caused small tumors to stop growing or even to shrink, researchers reported in the New England Journal of Medicine.
http://www.latimes.com/news/nationworld/nation/la-sci-prostate1-2010apr01,0,2741240.story
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment